Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Am J Rhinol Allergy. 2020 Mar;34(2):196-208. doi: 10.1177/1945892419884774. Epub 2019 Nov 1.

Chenjie Yu^{1

2

3}, Kaijian Wang², Xinyan Cui⁴, Ling Lu^{1

2

3}, Jianfei Dong^{1

2

3}, Maohua Wang⁵, Xia Gao^{1

2

3}

¹ Department of Otorhinolaryngology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Jiangsu Provincial Key Medical Discipline, Nanjing, The People's Republic of China.
² Department of Otorhinolaryngology, Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, The People's Republic of China.
³ Research Institute of Otorhinolaryngology, Drum Tower Hospital, Nanjing, The People's Republic of China.
⁴ Department of Otorhinolaryngology, The First Affiliated Hospital, Nanjing Medical University, Nanjing, The People's Republic of China.
⁵ Department of Otorhinolaryngology, Second Xiangya Hospital, Central South University, Changsha, The People's Republic of China.

No abstract available

Keywords: allergic rhinitis; anti-IgE; immunotherapy; meta-analysis; omalizumab.

Publication types